CAM
GILD icon

Congress Asset Management’s Gilead Sciences GILD Stock Holding History

Congress Asset Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-44,689
Closed -$3.54M – 261
2016
Q3 		$3.54M Buy
44,689
+1,939
+5% +$158K 0.08% 165
2016
Q2 		$3.57M Buy
42,750
+2,860
+7% +$254K 0.08% 154
2016
Q1 		$3.66M Buy
39,890
+1,158
+3% +$104K 0.09% 141
2015
Q4 		$3.92M Buy
38,732
+1,005
+3% +$105K 0.1% 137
2015
Q3 		$3.7M Buy
37,727
+1,451
+4% +$161K 0.1% 140
2015
Q2 		$4.25M Buy
+36,276
New +$3.96M 0.12% 141

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Congress Asset Management's GILD Position: Q4 2016 in Review

Congress Asset Management sold out of Gilead Sciences (GILD) in Q4 2016, closing a stake of 44,689 shares — an estimated $3.54M sold.

Congress Asset Management first reported a position in GILD in Q2 2015 and held it in 6 quarters. The position peaked at $4.25M in Q2 2015. 1,572 funds tracked by Wall St. Rank hold GILD as of Q4 2016.

  • Congress Asset Management reported no remaining Gilead Sciences position as of Q4 2016 after selling out during the quarter.
  • Congress Asset Management sold 44,689 Gilead Sciences shares in Q4 2016, an estimated $3.54M.
  • Congress Asset Management first reported a position in Gilead Sciences in Q2 2015 and held it in 6 quarters.
  • Congress Asset Management's Gilead Sciences position peaked at $4.25M in Q2 2015.
  • 1,572 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2016.

Based on Congress Asset Management's 13F filing for Q4 2016, filed 14 Feb 2017.